Clinical trial
Maraviroc in Rheumatoid Arthritis
NCT00427934
Study timeline
Study start (unknown)2007-02-01Date precision: month
Registry last updated2014-11-05
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Arthritis, Rheumatoidunresolved
Interventions
MaravirocDRUG · verified · RxNorm: maraviroc
Sponsors & collaborators
Pfizerlead sponsor
Mapped research locations
BerlinGermany2New HavenConnecticut, United States2LisbonPortugal2SavannahGeorgia, United States2GuadalajaraJalisco, Mexico2KalamazooMichigan, United States2San FranciscoCalifornia, United States1OmahaNebraska, United States1Las VegasNevada, United States1SyracuseNew York, United States1LeipzigGermany1KharkivUkraine1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00427934 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.